您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

王銘崇醫師

血癌及惡性淋巴瘤、惡性貧血、多發性骨髓瘤
  • 國語,英語,閩南語
  • 助理教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚血液腫瘤科副科主任
    • 高雄長庚醫院 血液腫瘤科主治醫師
  • 學歷
    • 中國醫藥學院
  • 經歷
    • 高雄長庚醫院 內科部住院醫師
    • 林口長庚醫院 血液腫瘤科住院醫師
    • 高雄長庚醫院 血液腫瘤科主治醫師
  • 學會與認證
    • 血液病學會會員
    • 內科醫學會會員
  • 論文及期刊發表
    • Correlation of low numbers of intratumoral FOXP3+ cells with worse progression-free survival in angioimmunoblastic T cell lymphoma. J Clin Pathol. 2023 Aug 24:jcp-2023-208932. doi: 10.1136/jcp-2023-208932. Online ahead of print.PMID: 37620127

      Liu HL, Weng SW, Chou CC, You HL, Wang MC, Ma MC, Huang WT.
    • Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma. In Vivo. 2023 Jul-Aug;37(4):1847-1856. doi: 10.21873/invivo.13276.PMID: 37369473Free PMC article.

      Liao PH, Chuang YH, Yang FS, Kuo CY, Ma MC, Liao CK, Wang MC.
    • Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN. Int J Mol Sci. 2023 May 14;24(10):8747. doi: 10.3390/ijms24108747.PMID: 37240094Free PMC article.

      Wang YH, Chen YJ, Lai YH, Wang MC, Chen YY, Wu YY, Yang YR, Tsou HY, Li CP, Hsu CC, Huang CE, Chen CC.
    • Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan. Br J Cancer. 2023 Mar;128(7):1294-1300. doi: 10.1038/s41416-023-02162-9. Epub 2023 Jan 30.PMID: 36717672

      Liu HC, Kuo MC, Wu KH, Chen TY, Chen JS, Wang MC, Lin TL, Yang Y, Ma MC, Wang PN, Sheen JM, Wang SC, Chen SH, Jaing TH, Cheng CN, Yeh TC, Lin TH, Shih LY.
    • Flow Cytometry Analysis Reveals a Wide Cytologic and Immunophenotypic Spectrum of Peripheral B Lymphocytes in Angioimmunoblastic T-Cell Lymphoma. Pathobiology. 2023;90(3):187-198. doi: 10.1159/000526284. Epub 2022 Nov 24.PMID: 36423589

      Liu HL, Liao CK, Weng SW, Shih LY, Chou CC, You HL, Wang MC, Huang WT.
    • Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis. J Hematol. 2022 Oct;11(5):176-184. doi: 10.14740/jh1054. Epub 2022 Oct 31.PMID: 36406829Free PMC article.

      Liao PH, Kuo CY, Ma MC, Liao CK, Pei SN, Wang MC.
    • Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia. Cancer Sci. 2022 Oct;113(10):3518-3527. doi: 10.1111/cas.15501. Epub 2022 Aug 17.PMID: 35869805Free PMC article.

      Su YJ, Kuo MC, Chen TY, Wang MC, Yang Y, Ma MC, Lin TL, Lin TH, Chang H, Teng CJ, Hsiao PC, Chen CC, Wang PN, Shih LY.
    • Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e751-e761. doi: 10.1016/j.clml.2022.04.005. Epub 2022 Apr 8.PMID: 35641409

      Sunami K, Ikeda T, Huang SY, Wang MC, Koh Y, Min CK, Yeh SP, Matsumoto M, Uchiyama M, Iyama S, Shimazaki C, Lee JH, Kim K, Kaneko H, Kim JS, Lin TL, Campana F, Tada K, Iida S, Suzuki K; ICARIA-MM study group.
    • Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data. PLoS One. 2022 Mar 17;17(3):e0265543. doi: 10.1371/journal.pone.0265543. eCollection 2022.PMID: 35298555Free PMC article.

      Su YC, Chiu BC, Li HJ, Yang WC, Chen TY, Yeh SP, Wang MC, Huang WT, Lee MY, Lin SF.
    • The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan. J Pers Med. 2022 Jan 19;12(2):130. doi: 10.3390/jpm12020130.PMID: 35207619Free PMC article.

      Du JS, Kuo YC, Shi HY, Wang MC, Wang LY, Chuang TM, Ke YL, Yeh TJ, Gau YC, Wang HC, Cho SF, Hsiao SY, Liu YC, Hsu CM, Hsiao HH.
    • Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial. Haematologica. 2021 Dec 1;106(12):3240-3244. doi: 10.3324/haematol.2021.279174.PMID: 34551506Free PMC article.Clinical Trial.No abstract available.

      Roboz GJ, Dohner H, Pocock C, Dombret H, Ravandi F, Jang JH, Selleslag D, Mayer J, Martens UM, Liesveld J, Bernal T, Wang MC, Yu P, Shi L, Guo S, La Torre I, Skikne B, Dong Q, Braverman J, Nehme SA, Beach CL, Wei AH.
    • Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab. Leuk Lymphoma. 2021 Dec;62(12):2899-2906. doi: 10.1080/10428194.2021.1948034. Epub 2021 Jul 29.PMID: 34323157

      Pei SN, Liu YF, Kuo CY, Wang MC, Ma MC, Liao CK, Ng HY, Chen CH.
    • Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. 2021 Jul;194(1):120-131. doi: 10.1111/bjh.17499. Epub 2021 May 25.PMID: 34036560Free PMC article.

      Harrison SJ, Perrot A, Alegre A, Simpson D, Wang MC, Spencer A, Delimpasi S, Hulin C, Sunami K, Facon T, Vlummens P, Yong K, Campana F, Inchauspe M, Mace S, Risse ML, van de Velde H, Richardson P. Br J Haematol.
    • A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan. Sci Rep. 2021 May 12;11(1):10069. doi: 10.1038/s41598-021-89316-y.PMID: 33980914Free PMC article.

      Pei SN, Wang MC, Ma MC, Kuo CY, Liao CK, Qiu H, Rothwell LA, Liu Y.
    • Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article. Medicine (Baltimore). 2021 May 7;100(18):e25798. doi: 10.1097/MD.0000000000025798.PMID: 33950978Free PMC article.

      Pan LL, Lee CH, Hung KC, Tsai IT, Wang MC, Sun CK.
    • Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2021 May;22(5):678-689. doi: 10.1016/S1470-2045(21)00145-5. Epub 2021 Apr 10.PMID: 33848462Clinical Trial.

      Matasar MJ, Capra M, Ozcan M, Lv F, Li W, Yanez E, Sapunarova K, Lin T, Jin J, Jurczak W, Hamed A, Wang MC, Baker R, Bondarenko I, Zhang Q, Feng J, Geissler K, Lazaroiu M, Saydam G, Szomor A, Bouabdallah K, Galiulin R, Uchida T, Soler LM, Cao A, Hiemeyer F, Mehra A, Childs BH, Shi Y, Zinzani PL.
    • The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma. J Formos Med Assoc. 2021 Nov;120(11):1967-1976. doi: 10.1016/j.jfma.2021.01.015. Epub 2021 Feb 4.PMID: 33551311

      Lu SY, Ma MC, Wang MC, Hsue SS.
    • Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population. Exp Mol Pathol. 2021 Feb;118:104577. doi: 10.1016/j.yexmp.2020.104577. Epub 2020 Nov 23.PMID: 33242451

      Chou CC, Tsao CF, Liao CK, You HL, Wang MC, Huang WT.
    • Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia. Int J Hematol. 2019 Dec;110(6):709-722. doi: 10.1007/s12185-019-02749-0. Epub 2019 Nov 13.PMID: 31655984Clinical Trial.

      Fujishima N, Uchida T, Onishi Y, Jung CW, Goh YT, Ando K, Wang MC, Ono C, Matsumizu M, Paccagnella ML, Sleight B, Vandendries E, Fujii Y, Hino M.
    • Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia. Br J Haematol. 2020 Mar;188(5):707-722. doi: 10.1111/bjh.16225. Epub 2019 Oct 14.PMID: 31610612Clinical Trial.

      Hsu CC, Chen YJ, Huang CE, Wu YY, Wang MC, Pei SN, Liao CK, Lu CH, Chen PT, Tsou HY, Li CP, Chuang WH, Chuang CK, Yang CY, Lai YH, Lin YH, Chen CC.
    • RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment. Exp Mol Pathol. 2019 Oct;110:104294. doi: 10.1016/j.yexmp.2019.104294. Epub 2019 Aug 5.PMID: 31394087

      Lee PH, Weng SW, Liu TT, You HL, Liao CK, Wang MC, Huang WT.
    • Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy? Pathol Int. 2018 Dec;68(12):712-714. doi: 10.1111/pin.12730. Epub 2018 Nov 6.PMID: 30402988No abstract available.

      Liao PH, Chou SC, Huang WT, Su YZ, Wang MC, Chuang SS.
    • Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study. PLoS One. 2018 Aug 2;13(8):e0201708. doi: 10.1371/journal.pone.0201708. eCollection 2018.PMID: 30071080Free PMC article.

      Wang MC, Huang CE, Lin MH, Yang YH, Lu CH, Chen PT, Wu YY, Tsou HY, Hsu CC, Chen CC.
    • TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018 Oct;80:145-151. doi: 10.1016/j.humpath.2018.05.026. Epub 2018 Jun 6.PMID: 29885407

      Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT.
    • A Newly Recognized Histologic Pattern of IgG4-related Lymphadenopathy: Expanding the Morphologic Spectrum. Am J Surg Pathol. 2018 Jul;42(7):977-982. doi: 10.1097/PAS.0000000000001076.PMID: 29738364

      Chen YR, Chen YJ, Wang MC, Medeiros LJ, Chang KC.
    • A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients. Sci Rep. 2017 Sep 12;7(1):11253. doi: 10.1038/s41598-017-10542-4.PMID: 28900115Free PMC article.Clinical Trial.

      Tsai HJ, Jiang SS, Hung WC, Borthakur G, Lin SF, Pemmaraju N, Jabbour E, Bomalaski JS, Chen YP, Hsiao HH, Wang MC, Kuo CY, Chang H, Yeh SP, Cortes J, Chen LT, Chen TY.
    • A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan. J Formos Med Assoc. 2017 Sep;116(9):705-710. doi: 10.1016/j.jfma.2016.11.005. Epub 2016 Dec 21.PMID: 28012677

      Huang SY, Yu YB, Yeh SP, Chen TY, Kao WY, Chen CC, Wang MC, Lin HY, Lin SF, Lin TH, Hua Y, Puccio-Pick M, DeMarco D, Jacques C, Dunn P.
    • Characteristics of Taiwanese patients of PNH in the international PNH registry. Thromb J. 2016 Oct 4;14(Suppl 1):39. doi: 10.1186/s12959-016-0094-0. eCollection 2016.PMID: 27766064Free PMC article.

      Chou WC, Huang WH, Wang MC, Chang CS, Yeh SP, Chiou TJ, Chen YC, Lin TH, Shen MC; Taiwan PNH study group.
    • Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016 Mar;124(3):216-20. doi: 10.1111/apm.12492. Epub 2015 Dec 14.PMID: 26660641

      Liu TT, Weng SW, Wang MC, Huang WT.
    • Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura. Transl Res. 2015 Dec;166(6):750-761.e4. doi: 10.1016/j.trsl.2015.09.005. Epub 2015 Sep 30.PMID: 26477577

      Chiou TJ, Chang YF, Wang MC, Kao CW, Lin HY, Chen TY, Hsueh EJ, Lan YJ, Sung YC, Lin SF, Bai LY, Chen CG.
    • Genetic disposition and modifiable factors independently associated with anemia in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015 Apr;108(1):164-9. doi: 10.1016/j.diabres.2014.12.012. Epub 2015 Jan 21.PMID: 25656761

      Chiou TT, Lee JJ, Wang MC, Chung MS, Pan LL, Hsieh CJ, Huang ST, Chang HW, Yang KD, Lee CT, Liu RT.
    • Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis. Leuk Lymphoma. 2015 Jul;56(7):2067-74. doi: 10.3109/10428194.2014.969260. Epub 2014 Nov 20.PMID: 25315076Clinical Trial.

      Jung CW, Shih LY, Xiao Z, Jie J, Hou HA, Du X, Wang MC, Park S, Eom KS, Oritani K, Okamoto S, Tauchi T, Kim JS, Zhou D, Saito S, Li J, Handa H, Jianyong L, Ohishi K, Hou M, Depei W, Takenaka K, Liu T, Hu Y, Amagasaki T, Ito K, Gopalakrishna P, Akashi K.
    • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial. Lancet Oncol. 2014 Oct;15(11):1195-206. doi: 10.1016/S1470-2045(14)70440-1. Epub 2014 Sep 18.PMID: 25242045Clinical Trial.

      San-Miguel JF, Hungria VT, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, Gunther A, Nakorn TN, Siritanaratkul N, Corradini P, Chuncharunee S, Lee JJ, Schlossman RL, Shelekhova T, Yong K, Tan D, Numbenjapon T, Cavenagh JD, Hou J, LeBlanc R, Nahi H, Qiu L, Salwender H, Pulini S, Moreau P, Warzocha K, White D, Blade J, Chen W, de la Rubia J, Gimsing P, Lonial S, Kaufman JL, Ocio EM, Veskovski L, Sohn SK, Wang MC, Lee JH, Einsele H, Sopala M, Corrado C, Bengoudifa BR, Binlich F, Ri
    • Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Hematol Oncol. 2015 Dec;33(4):136-44. doi: 10.1002/hon.2161. Epub 2014 Aug 11.PMID: 25111959Clinical Trial.

      Hsiao LT, Tien HF, Kuo CY, Wu JH, Hou HA, Wang MC, Liu CY, Chen PM, Chiou TJ.
    • Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2430-7. eCollection 2014.PMID: 24966953Free PMC article.

      Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    • TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age. Int J Med Sci. 2014 Apr 16;11(6):614-9. doi: 10.7150/ijms.8582. eCollection 2014.PMID: 24782651Free PMC article.

      Pei SN, Ma MC, You HL, Fu HC, Kuo CY, Rau KM, Wang MC, Lee CT.
    • Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14.PMID: 24002804

      Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group.
    • Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature. Int J Clin Exp Pathol. 2013;6(1):105-9. Epub 2012 Nov 20.PMID: 23236550Free PMC article.Review.

      He HL, Wang MC, Huang WT.
    • Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leuk Res. 2013 Jan;37(1):43-9. doi: 10.1016/j.leukres.2012.09.012. Epub 2012 Oct 9.PMID: 23062378

      Shih LY, Kuo MC, Kuo CY, Lin TH, Bai LY, Chen TY, Wang MC, Lin TL, Lan YJ, Chen CC, Yang Y, Hsiao PC, Lai CL, Chang CH, Lin TH.
    • Lee C-H, Wang M-C, Huang I-W, Chen F-J, Lauderdale T-L*. Development of Daptomycin Nonsusceptibility with Heterogeneous Vancomycin-Intermediate Resistance and Oxacillin Susceptibility in Methicillin-Resistant Staphylococcus aureus during High-Dose Daptomycin Treatment. Antimicrob Agents Chemother. 2010; 54(9):4038-40.(SCI;IF=4.672; Pharmacology & pharmacy 21/216)

    • Chen J-Y, Wang M-C, Hung W-C*. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. Journal of Cellular Physiology. 2011; 226(2):407-13. (SCI IF=3.874; Phsyiology 12/79)

    • Liang C-M, Wang M-C, Chen Y-J, Hung C-H*, Hu T-H. Primary Duodenal Mucosa-Associated Lymphoid Tissue Lymphoma: Report of a Case. Gastroenterol J Taiwan 2011;28:40-6

    • Wang M-C , Yang K-T, Chen J-Y, Hsu M-C, Hung W-C*. Bcr-Abl oncogene stimulates jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells. Journal of Cellular Physiology 2011;226:2849-56 (first author, Yang K-T, Wang M-C, Chen J-Y contributed equally to this work) (SCI;IF=3.874; Physiology 12/79)

    • Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH*. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Ann Hematol. 2012 Jul;91(7):1007-12 (SCI;IF=2.688; Hematology 33/65)